Matches in Wikidata for { <http://www.wikidata.org/entity/Q66063236> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66063236 description "clinical trial" @default.
- Q66063236 description "ensayu clínicu" @default.
- Q66063236 description "klinisch onderzoek" @default.
- Q66063236 description "клінічне випробування" @default.
- Q66063236 name "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 name "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 type Item @default.
- Q66063236 label "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 label "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 prefLabel "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 prefLabel "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 P1050 Q66063236-5B21A7CD-EA80-4FF8-9C66-96DD63EBD4C4 @default.
- Q66063236 P1132 Q66063236-626ECE5B-F8BB-4BE6-A3DB-C1576A584645 @default.
- Q66063236 P1476 Q66063236-9E871603-3FB6-4109-85C9-EF3FAABFF8A4 @default.
- Q66063236 P2899 Q66063236-833DEADC-9345-4BEC-870F-0EEB3F410D63 @default.
- Q66063236 P3098 Q66063236-32136CA8-D73E-4400-9C51-8E4DB7BBD1EB @default.
- Q66063236 P31 Q66063236-32E11E7B-1214-4C5E-BE46-9E731C2A9285 @default.
- Q66063236 P580 Q66063236-9E8D1680-B8C7-43C1-A25C-7130C51C8638 @default.
- Q66063236 P582 Q66063236-5D51A1D4-E15E-4200-8911-FED741310D2B @default.
- Q66063236 P6099 Q66063236-35E10CEC-6BFF-4AE2-B7DE-DCBBA3B8C322 @default.
- Q66063236 P6099 Q66063236-CA601C52-4A4E-44F2-AE36-3A1886C02C28 @default.
- Q66063236 P8363 Q66063236-E299F3D0-0E73-45B6-A508-22E9C57687AC @default.
- Q66063236 P1050 Q124292 @default.
- Q66063236 P1132 "+42" @default.
- Q66063236 P1476 "Phase Ib Study to Evaluate the Pharmacokinetics, Safety and Efficacy of TQB2450 Injection(PD-L1 Antibody) Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma" @default.
- Q66063236 P2899 "+18" @default.
- Q66063236 P3098 "NCT03996408" @default.
- Q66063236 P31 Q30612 @default.
- Q66063236 P580 "2019-06-30T00:00:00Z" @default.
- Q66063236 P582 "2020-12-31T00:00:00Z" @default.
- Q66063236 P6099 Q42824440 @default.
- Q66063236 P6099 Q5452194 @default.
- Q66063236 P8363 Q78089383 @default.